- Home
- EVO vs EVT Comparison
EVO vs EVT Comparison
Compare EVO & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- EVT
- Stock Information
- Founded
- EVO 1993
- EVT 2003
- Country
- EVO Germany
- EVT United States
- Employees
- EVO N/A
- EVT N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- EVT Finance Companies
- Sector
- EVO Health Care
- EVT Finance
- Exchange
- EVO Nasdaq
- EVT Nasdaq
- Market Cap
- EVO 1.5B
- EVT 1.7B
- IPO Year
- EVO 2021
- EVT N/A
- Fundamental
- Price
- EVO $4.26
- EVT $24.23
- Analyst Decision
- EVO Buy
- EVT
- Analyst Count
- EVO 2
- EVT 0
- Target Price
- EVO $5.90
- EVT N/A
- AVG Volume (30 Days)
- EVO 95.8K
- EVT 115.5K
- Earning Date
- EVO 08-13-2025
- EVT 01-01-0001
- Dividend Yield
- EVO N/A
- EVT 8.32%
- EPS Growth
- EVO N/A
- EVT N/A
- EPS
- EVO N/A
- EVT 6.63
- Revenue
- EVO $851,944,444.00
- EVT $69,404,302.00
- Revenue This Year
- EVO $10.08
- EVT N/A
- Revenue Next Year
- EVO $10.99
- EVT N/A
- P/E Ratio
- EVO N/A
- EVT $3.55
- Revenue Growth
- EVO 1.50
- EVT N/A
- 52 Week Low
- EVO $2.84
- EVT $19.20
- 52 Week High
- EVO $5.64
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- EVO 55.61
- EVT 58.73
- Support Level
- EVO $3.64
- EVT $23.90
- Resistance Level
- EVO $4.36
- EVT $24.35
- Average True Range (ATR)
- EVO 0.09
- EVT 0.20
- MACD
- EVO -0.01
- EVT -0.03
- Stochastic Oscillator
- EVO 86.11
- EVT 70.66
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.